Last reviewed · How we verify
NCT03069729
Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)
trial testing no intervention in Diabetic Neuropathies in 331 participants. Completed in 1 September 2019.
1 August 2019
Quick facts
| Lead sponsor | VisionQuest Biomedical LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 331 |
| Start date | 8 March 2017 |
| Primary completion | 1 August 2019 |
| Estimated completion | 1 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- no intervention
Conditions studied
- Diabetic Neuropathies — all drugs for Diabetic Neuropathies →
- Diabetic Foot — all drugs for Diabetic Foot →
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
Sponsor
VisionQuest Biomedical LLC
Who can join
Adults 35 to 76, any sex, with Diabetic Neuropathies or Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this research is to develop better tools for diagnosing illness of the feet and legs of people who have diabetes. Investigators will use thermal videos of the foot to aid in the refinement of a system designed to detect signs of diabetic peripheral neuropathy (DPN). The team of investigators will also look at diabetic eye disease and how it might relate to diabetic foot disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03069729
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of no intervention
Trials testing the same drug.
- NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
- NCT07253506 — Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale i · not yet recruiting
- NCT07253519 — The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke · not yet recruiting
- NCT07194096 — Stress Hyperglycemia Ratio and Postoperative Delirium · not yet recruiting
- NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting
Other recruiting trials for Diabetic Neuropathies
Currently open trials in the same condition.
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
- NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
- NCT06798181 — Neuropathic Pain and Type II Diabetic Patients · recruiting
Other VisionQuest Biomedical LLC trials
Trials by the same sponsor.
- NCT06915285 — Automated Detection of Malarial Retinopathy in Patients Diagnosed With Cerebral Malaria · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03069729 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VisionQuest Biomedical LLC
- Last refreshed: 12 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03069729.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing